Effects of phencyclidine on spatial learning and memory: nitric oxide-dependent mechanisms

Area of Science:

• Neuroscience
• Psychopharmacology
• Cognitive Science

Background:

• Cognitive deficits are a core feature of schizophrenia, impacting treatment and functional outcomes.
• Phencyclidine (PCP), an NMDA receptor antagonist, is used to model cognitive dysfunction in schizophrenia.
• The Morris water maze is a standard paradigm for assessing spatial learning and memory.

Purpose of the Study:

• To investigate the effects of PCP on spatial learning and reference memory in rats.
• To determine if nitric oxide synthase inhibition can mitigate PCP-induced cognitive deficits.
• To assess potential state-dependent effects of PCP on memory recall.

Main Methods:

• Rats received acute administration of PCP (0.5-2.0 mg/kg) before acquisition trials in the Morris water maze.
• Reference memory was assessed via probe trials, with and without drug treatment, to check for state dependency.
• The effect of L-NAME (a nitric oxide synthase inhibitor) pre-treatment on PCP-induced deficits was evaluated.

Main Results:

• PCP at 2 mg/kg significantly impaired spatial learning and reference memory acquisition and retrieval.
• No state-dependent learning effects of PCP were observed.
• L-NAME pre-treatment fully reversed PCP-induced acquisition learning deficits but only partially restored reference memory.

Conclusions:

• PCP reliably induces spatial memory impairments in rats, serving as a relevant model for schizophrenia.
• Nitric oxide synthase inhibition shows therapeutic potential for PCP-induced cognitive deficits, particularly during learning.
• Further research is needed to fully address reference memory impairments in this model.